Vasomotor responses to hypoxia in type 2 diabetes

Cara J. Weisbrod, Peter R. Eastwood, Gerard O'Driscoll, Jennifer H. Walsh, Matthew Best, John R. Halliwill, Daniel J. Green

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Abstract

Type 2 diabetes is associated with vascular dysfunction, accelerated atherosclerotic morbidity, and mortality. Abnormal vasomotor responses to chemoreflex activation may contribute to the acceleration of atherosclerotic diabetes complications, but these responses have not previously been investigated. We measured forearm mean blood flow (MBF) and mean vascular conductance (MVC) responses to isocapnic hypoxia in seven healthy and eight type 2 diabetic subjects during local intra-arterial saline infusion and α-adrenergic blockade (phentolamine). The effects of hypoxia on saline and phentolamine responses significantly differed between groups; relative to normoxia, the %ΔMVC with hypoxia during saline was -3.3 ± 11.2% in control and 24.8 ± 13.3% in diabetic subjects, whereas phentolamine increased hypoxic %ΔMVC to similar levels (39.4 ± 9.7% in control subjects and 48.0 ± 11.8% in diabetic subjects, P < 0.05, two-way ANOVA). Absolute normoxic MBF responses during saline infusion were 91.9 ± 21.1 and 77.9 ± 15.3 in control and diabetic subjects, respectively, and phentolamine increased normoxic MBF to similar levels (165.2 ± 40.1 ml/min in control subjects and 175.9 ± 32.0 ml/min in diabetic subjects; both P < 0.05). These data indicate that diabetic and control subjects exhibit similar responses to hypoxia in the presence of α-adrenergic blockade despite evidence of exaggerated α-mediated vasoconstriction at rest.

Original languageEnglish
Pages (from-to)2073-2078
Number of pages6
JournalDiabetes
Volume53
Issue number8
DOIs
Publication statusPublished - Aug 2004
Externally publishedYes

Bibliographical note

Copyright:
Copyright 2010 Elsevier B.V., All rights reserved.

Fingerprint Dive into the research topics of 'Vasomotor responses to hypoxia in type 2 diabetes'. Together they form a unique fingerprint.

Cite this